Developing Medical Innovation

We develop new technologies from the NHS and beyond to improve patient care

Realising Potential

** COVID-19 pandemic: Medovate remains fully operational during this time. Team members are able to work seemlessly from home and can be contacted via phone and e-mail. Please see latest news below for full details on how Medovate is operating during the current situation. **

Medovate is a dynamic medical device company dedicated to the development and commercialisation of innovative medical technologies created within the NHS.

Medovate provides technical, management and financial support to develop medical devices through clinical trials, regulatory approval and market launch, in order to improve patient safety and healthcare delivery.

Our current pipeline of novel medical technologies is focussed on anaesthesia, airway, critical care and surgery.

Read More

Latest News

Keep up to date with Medovate News & Events


Medovate to bring life-saving upper GI therapy device to market

23rd March, 2020

Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device. The new device, ENDOVAC, has the potential to dramatically improve survival of patients with life threatening infection following a leak from their the upper gastrointestinal (GI) tract whilst significantly enhancing current treatment methods.


Medovate remains fully operational during COVID-19 pandemic

19th March, 2020

​During the current situation concerning the COVID-19 pandemic, we would like to reassure you that you can continue to contact Medovate as normal as our team are working from home. Click to read full details of how we are remaining operational and how to contact the Medovate team during this time.


Medovate unveils US launch plans for regional anaesthesia innovation

4th February, 2020

Medovate is breaking into the US market with the launch of the FDA approved SAFIRA regional anaesthesia innovation, at ASRA 2020 (the 45th Annual Regional Anesthesiology and Acute Pain Medicine Meeting), taking place in San Francisco on the 23rd - 25th April. In addition to this, Medovate has also joined the Association of British Healthcare Industries (ABHI) US Accelerator.